Past events
View our past events
ICH S1B(R1) industry and regulatory best practice for confident carcinogenicity assessment (in Japanese)
Webinar
- 10 March 2026
- Japanese
- Online
This webinar is a replay designed for our Japanese-speaking scientific community, with presentations available as recordings featuring embedded Japanese subtitles.
The ICH S1B(R1) addendum is a globally recognised guideline that introduces a weight-of-evidence (WoE) approach to assessing the carcinogenic potential of pharmaceuticals.
10th Impurities: Genotoxic, Nitrosamine, & Beyond Summit
Conference
- 4 - 5 March 2026
- English
- In-person
The 10th Impurities: Genotoxic, Nitrosamine & Beyond Summit I #Egenotoxic 2026 is one of the most respected and widely attended gatherings in the field of pharmaceutical impurity control.
Forced degradation problem solving (in Japanese)
Webinar
- 24 February 2026
- Japanese
- Online
強制分解の問題解決
This session was hosted in Japanese or with Japanese subtitles.
Supporting forced degradation studies with in silico tools as part of your workflow.
From theory to practice: How to apply ICH M7(R2) in the assessment of (potentially) mutagenic impurities
Webinar
- 11 December 2025
- Portuguese
- Online
Thursday 11th December
13:00 – 15:00 (BRT)
This webinar was delivered entirely in Portuguese.
Are you looking to strengthen your understanding of the ICH M7(R2) guideline and learn practical approaches to conducting compliant impurity risk assessments?
IGG Annual meeting 2025
Conference
- 2 December 2025
- In-person
The 2025 IGG annual meeting aims to discuss and establish a position regarding the consideration and implementation of biological relevance. The Transgenic Rodent Assay (TGR) will be considered due to recent changes to the OECD 488 guidelines, but the broader impact on industry will also be discussed.